Approval · Notice of Compliance 13619 · 2012
XIAFLEX: Notice of Compliance 13619
Issued September 4, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13619
- Date
- September 4, 2012
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Collagenase Clostridium Hystolyticum
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| XIAFLEX | 02388316 | Cancelled Post Market |
Medicinal ingredients
- COLLAGENASE CLOSTRIDIUM HISTOLYTICUM 0.9 MG per VIAL